Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3749-3754

  Lee, Andie S ^a,b   Gizard, Yann ^a   Empel, Joanna ^c   Bonetti, Eve Julie ^a   Harbarth, Stephan ^a   François, Patrice ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID; ANTIINFECTIVE AGENT; BACTERIAL DNA; ISOLEUCINE TRANSFER RNA LIGASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOUBLING TIME; DRUG EXPOSURE; FITNESS COST; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC BACKGROUND; GENETIC PARAMETERS; GENETIC PROCEDURES; GENETIC STABILITY; GENETIC VARIABILITY; GENOTYPE; ILES GENE; IN VITRO STUDY; INCUBATION TIME; LOW LEVEL ANTIBIOTIC RESISTANCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; MULTILOCUS VARIABLE NUMBER TANDEM REPEAT ASSAY; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; POINT MUTATION; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENETIC SELECTION; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MISSENSE MUTATION;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; ISOLEUCINE-TRNA LIGASE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; MUTATION, MISSENSE; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84907164425     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01010-14     Document Type: Article

References (29)

1. Datta R, Huang SS. 2008. Risk of infection and death due to methicillinresistant Staphylococcus aureus in long-term carriers. Clin. Infect. Dis. 47:176-181. http://dx.doi.org/10.1086/589241.
2. von Eiff C, Becker K, Machka K, Stammer H, Peters G. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16. http://dx.doi.org/10.1056/NEJM200101043440102.
3. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC. 2010. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362:9-17. http://dx.doi.org/10.1056/NEJMoa0808939.
4. Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, Braun B, Herwaldt L. 2013. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive sur-gical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 346:f2743. http://dx.doi.org/10.1136/bmj.f2743.
5. Harbarth S. 2006. Control of endemic methicillin-resistant Staphylococcus aureus-recent advances and future challenges. Clin. Microbiol. Infect. 12:1154-1162. http://dx.doi.org/10.1111/j.1469-0691.2006.01572.x.
6. Simor AE. 2011. Staphylococcal decolonisation: an effective strategy for prevention of infection? Lancet Infect. Dis. 11:952-962. http://dx.doi.org/10.1016/S1473-3099(11)70281-X.
7. Hurdle JG, ONeill AJ, Mody L, Chopra I, Bradley SF. 2005. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J. Antimicrob. Chemother. 56:1166-1168. http://dx.doi.org/10.1093/jac/dki387.
8. Patel JB, Gorwitz RJ, Jernigan JA. 2009. Mupirocin resistance. Clin. Infect. Dis. 49:935-941. http://dx.doi.org/10.1086/605495.
9. Lee AS, Macedo-Vinas M, Francois P, Renzi G, Schrenzel J, Vernaz N, Pittet D, Harbarth S. 2011. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a casecontrol study. Clin. Infect. Dis. 52:1422-1430. http://dx.doi.org/10.1093/cid/cir233.
10. Thomas CM, Hothersall J, Willis CL, Simpson TJ. 2010. Resistance to and synthesis of the antibiotic mupirocin. Nat. Rev. Microbiol. 8:281-289. http://dx.doi.org/10.1038/nrmicro2278.
11. Lee AS, Macedo-Vinas M, Francois P, Renzi G, Vernaz N, Schrenzel J, Pittet D, Harbarth S. 2011. Trends in mupirocin resistance in meticillinresistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J. Hosp. Infect. 77:360-362. http://dx.doi.org/10.1016/j.jhin .2010.11.002.
12. Wysmolinska A, Orczykowska-Kotyna M, Komorowska I, Kozinska A, Empel J, Lee A, Harbarth S, Malhotra-Kumar S, Goossens H, Hryniewicz W. 2012. Clonal structure of MRSA isolates from surgical wards in Europe and Israel. Abstr. 22nd Eur. Cong. Clin. Microbiol. Infect. Dis., abstr 0266.
13. Francois P, Huyghe A, Charbonnier Y, Bento M, Herzig S, Topolski I, Fleury B, Lew D, Vaudaux P, Harbarth S, van Leeuwen W, van Belkum A, Blanc DS, Pittet D, Schrenzel J. 2005. Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J. Clin. Microbiol. 43:3346-3355. http://dx.doi.org/10.1128/JCM.43.7.3346-3355.2005.
14. Koessler T, Francois P, Charbonnier Y, Huyghe A, Bento M, Dharan S, Renzi G, Lew D, Harbarth S, Pittet D, Schrenzel J. 2006. Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:1040-1048. http://dx.doi.org/10 .1128/JCM.44.3.1040-1048.2006.
15. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
16. Mody L, Kauffman CA, McNeil SA, Galecki AT, Bradley SF. 2003. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebocontrolled trial. Clin. Infect. Dis. 37:1467-1474. http://dx.doi.org/10.1086/379325.
17. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A. 2007. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin. Infect. Dis. 44:178-185. http://dx.doi.org/10.1086/510392.
18. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program. 2013. Targeted versus universal decolonization to prevent ICU infection. N. Engl. J. Med. 368:2255-2265. http://dx.doi.org/10.1056/NEJMoa1207290.
19. OReilly T, Zak O. 1992. Elevated body temperature restricts growth of Haemophilus influenzae type b during experimental meningitis. Infect. Immun. 60:3448-3451.
20. van der Mee-Marquet N, Franois P, Domelier-Valentin AS, Coulomb F, Decreux C, Hombrock-Allet C, Lehiani O, Neveu C, Ratovohery D, Schrenzel J, Quentin R; Bloodstream Infection Study Group of Réseau des Hygiénistes du Centre (RHC). 2011. Emergence of unusual bloodstream infections associated with pig-borne-like Staphylococcus aureus ST398 in France. Clin. Infect. Dis. 52:152-153. http://dx.doi.org/10.1093/cid/ciq053.
21. Antonio M, McFerran N, Pallen MJ. 2002. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:438-442. http://dx.doi.org/10.1128/AAC.46.2.438-442.2002.
22. Watanabe H, Masaki H, Asoh N, Watanabe K, Oishi K, Kobayashi S, Sato A, Sugita R, Nagatake T. 2001. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 39:3775-3777. http://dx.doi.org/10.1128/JCM .39.10.3775-3777.2001.
23. Upton A, Lang S, Heffernan H. 2003. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J. Antimicrob. Chemother. 51:613-617. http://dx.doi.org/10.1093/jac/dkg127.
24. Walker ES, Levy F, Shorman M, David G, Abdalla J, Sarubbi FA. 2004. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. J. Clin. Microbiol. 42:2792-2795. http://dx.doi.org/10.1128/JCM.42.6.2792-2795.2004.
25. Mongkolrattanothai K, Pumfrey L, Mankin P, Gray BM. 2009. Acquisition of high-level mupirocin resistance and its fitness cost among methicillin-resistant Staphylococcus aureus strains with low-level mupirocin resistance. J. Clin. Microbiol. 47:4158-4160. http://dx.doi.org/10.1128/JCM.01022-09.
26. Hurdle JG, ONeill AJ, Ingham E, Fishwick C, Chopra I. 2004. Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques. Antimicrob. Agents Chemother. 48:4366-4376. http://dx.doi.org/10.1128/AAC.48.11.4366-4376 .2004.
27. Walker ES, Vasquez JE, Dula R, Bullock H, Sarubbi FA. 2003. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect. Control Hosp. Epidemiol. 24:342-346. http://dx.doi.org/10.1086/502218.
28. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
29. Biedenbach DJ, Bouchillon SK, Johnson SA, Hoban DJ, Hackel M. 2014. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study. Clin. Ther. 36:953-960. http://dx.doi.org/10.1016/j.clinthera.2014.04.003.